Bavarian Nordic A/S (BAVA.CO)
BAVA.CO on Copenhagen Stock Exchange
Price Change (% chg)
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines within biodefence, cancer and infectious diseases therapeutic areas. The Company operates within two segments: Cancer Vaccines and Infectious Disease. The Cancer Vaccines’ pipeline is focused on... (more)
|Market Cap (Mil.):||kr.2,400.68|
|Shares Outstanding (Mil.):||26.09|
Earnings vs. Estimates
Analyst Research Reports
Bavarian Nordic A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.